Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BioSource Europe AB
AB
Active
Org 5565894119
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2000 · 26 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
BioSource Europe AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2022: 2M
2M
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
2M
2M
1M
1M
0M
2022: 2M
2M
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2023
2022
Revenue
0
−0
31
388
2 150
Staff expenses
—
−0
−24
−109
−130
EBITDA
−52
−18
−119
30
1 760
Depreciation & amort.
—
—
—
—
—
EBIT
−52
−18
−119
30
1 760
Net financials
37
76
133
93
−98
Profit before tax
223
35
14
123
1 244
Tax
−54
−14
−5
−13
−259
Net profit
169
21
9
109
985
Balance sheet
SEK thousands
Item
2025
2024
2023
2023
2022
Total assets
4 155
4 392
4 572
4 563
5 139
Equity
2 934
2 975
2 954
3 149
3 240
Long-term debt
—
—
—
—
—
Short-term debt
93
52
276
72
558
Total debt
93
52
276
72
558
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2022
2025
Equity ratio
70,6 %
This company
38,2 %
Market median
This company
Market median
85% above market
2022
2025
Return on equity
5,7 %
This company
18,4 %
Market median
This company
Market median
69% below market
2022
2025
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2022
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2022
2025
Debt / equity
0,42×
This company
0,62×
Market median
This company
Market median
32% below market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2023-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
More on BioSource Europe AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
